🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
PFE
NYSE
🇺🇸 US
Pfizer Inc.
Pharmaceuticals
13Score
DipBuster Score™
$30.42
+$0.57 (+0%)
Live price · Source: FMP-live
52-Week Position
$23.62
100% of range
$30.44
Dividend
—
no income
Mkt Cap
$173.38B
total value
Mkt Cap$173.38B
P/EN/A
DividendNone
BetaN/A
52W High$30.44
52W Low$23.62
DipBuster Brief
Key signals at a glance
Zone: Sell / Avoid
Bearish
Near 52-Week High — Asymmetric Risk
At 100% of its annual range the stock is close to its peak. New buyers face limited upside and meaningful downside if sentiment shifts.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt Cap$173.38B
52W Position100% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta—
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at Pfizer Inc. (PFE), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-10-15 | Bourla Albert | BUY | 20 |
| 2026-10-13 | Bourla Albert | BUY | 71 |
| 2026-09-30 | Bourla Albert | BUY | 21 |
| 2026-09-25 | Buckley Mortimer J | BUY | 1,308 |
| 2026-09-25 | Echevarria Joseph | BUY | 1,613 |
| 2026-09-25 | Smith James C | BUY | 1,570 |
| 2026-09-25 | Quincey James | BUY | 1,352 |
| 2026-09-25 | Taraporevala Cyrus | BUY | 1,308 |
| 2026-09-25 | Narayen Shantanu | BUY | 1,744 |
| 2026-09-15 | Bourla Albert | BUY | 22 |
Valuation
P/E RatioN/A
Market Cap$173.38B
BetaN/A
Dividend/yrNone
52W High$30.44
52W Low$23.62
52-Week Range
$23.62Now$30.44
100% through annual range
From 52W High−0.1%
From 52W Low+28.8%
📖 Plain English Summary
Pfizer Inc. is at 100% of its 52-week range.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for PFE
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — PFE
Heuristic · balance sheet, insider filings, price data, academic research
Pfizer Inc. — DipBuster Score 13/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track Pfizer Inc. free
Add PFE to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
0/25
Momentum & Volume
8/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
1
/100 · NEUTRAL
dip depth
0/25
oversold rsi
0/25
mean reversion
0/15
insider zone
1/25
capitulation
0/10
Insiders' avg buy price: $25.77 — marked 🟡 on the chart above.
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 13/100
📊
Run a full check in the AI analysis tab for a deeper look.